BE541853A - - Google Patents
Info
- Publication number
- BE541853A BE541853A BE541853DA BE541853A BE 541853 A BE541853 A BE 541853A BE 541853D A BE541853D A BE 541853DA BE 541853 A BE541853 A BE 541853A
- Authority
- BE
- Belgium
- Prior art keywords
- antibiotic
- tetracycline
- weight
- fungicidin
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 23
- 230000003115 biocidal effect Effects 0.000 claims description 17
- 229930101283 tetracycline Natural products 0.000 claims description 10
- 239000004098 Tetracycline Substances 0.000 claims description 9
- 229960002180 tetracycline Drugs 0.000 claims description 9
- 235000019364 tetracycline Nutrition 0.000 claims description 9
- 150000003522 tetracyclines Chemical class 0.000 claims description 9
- 239000013543 active substance Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000003981 vehicle Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 229940072172 tetracycline antibiotic Drugs 0.000 description 5
- 241000233866 Fungi Species 0.000 description 3
- 241001363490 Monilia Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000004099 Chlortetracycline Substances 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 2
- 229960004475 chlortetracycline Drugs 0.000 description 2
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 2
- 235000019365 chlortetracycline Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 2
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 2
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 2
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE541853A true BE541853A (enrdf_load_stackoverflow) |
Family
ID=170696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE541853D BE541853A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE541853A (enrdf_load_stackoverflow) |
-
0
- BE BE541853D patent/BE541853A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2606875C (fr) | Combinaison pharmaceutique comprenant un antibiotique et une substance active choisie parmi le carveol, le thymol, le carvacrol, l'alpha-ionone et beta-ionone | |
| EP2124961B1 (fr) | Nouvelle composition à base d'oxime de cholest-4-èn-3-one | |
| FR2535720A1 (fr) | Complexe d'inclusion de cyclodextrine avec le butylate de piperonyle et procede pour sa preparation | |
| BE895724A (fr) | Nouvelle utilisation therapeutique de la dihydrocyclosporine d | |
| DE69104362T2 (de) | Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen. | |
| EP2165704B1 (fr) | Utilisation de l'alvérine dans le traitement des affections cutanées | |
| CA1103154A (fr) | Compositions pharmaceutiques renfermant des derives organiques de la montmorillonite | |
| EP3429611B1 (fr) | Polycomplexes de composes poly-lysine pour la prevention et/ou la lutte contre la sclerose laterale amyotrophique | |
| BE541853A (enrdf_load_stackoverflow) | ||
| BE1000189A3 (fr) | Preparation pharmaceutique a usage veterinaire. | |
| FR2472389A1 (fr) | Compositions antibiotiques contenant un macrolide et un aminoheteroside | |
| JPH06507917A (ja) | 抗真菌剤 | |
| FR2547730A1 (fr) | Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie | |
| FR2566663A1 (fr) | Vermicide a base de mebendazole et procede pour la preparation de ce vermicide | |
| CA1187785A (fr) | Medicament a base de l-methionine | |
| US4609665A (en) | Use of selected pyridine-N-oxide disulfide compounds to treat or prevent swine exudative epidermitis | |
| BE551953A (enrdf_load_stackoverflow) | ||
| BE628615A (enrdf_load_stackoverflow) | ||
| BE723288A (enrdf_load_stackoverflow) | ||
| FR2609714A1 (fr) | Compositions liquides stables a base de derives antifongiques imidazoles | |
| BE553536A (enrdf_load_stackoverflow) | ||
| BE556491A (enrdf_load_stackoverflow) | ||
| CN1224353A (zh) | 维及霉素混合物 | |
| WO1984004249A2 (fr) | Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires | |
| BE571622A (enrdf_load_stackoverflow) |